WCLC 2022 Conference Coverage


 

WCLC 2022: Adding Alectinib Rescues Progression on Osimertinib Due to Acquired ALK p.R1275Q Variant in EGFR p.L858R-Mutated NSCLC

43 views
August 18, 2022
Comments 0
Login to view comments. Click here to Login